For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Trellis Bioscience, Inc.

USPTO Granted Patents = 30

% Expired Patents = 26.7

CIPO Patents = 2

EPO Patents = 5

Forward Citations = 169

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Lawrence M Kauvar (30 out of 84 patents)

Angeles Estelles (10 out of 11 patents)

Stefan Ryser (8 out of 8 patents)

4. Orit Foord (7 out of 78 patents)

5. Gizette Sperinde (6 out of 8 patents)

6. Ellen J Collarini (6 out of 9 patents)

7. Minha Park (5 out of 7 patents)

8. Stote Ellsworth (5 out of 5 patents)

9. William Usinger (5 out of 9 patents)

10. Krista Maureen McCutcheon (5 out of 14 patents)

11. Bo Chen (4 out of 6 patents)

12. Reyna J Simon (4 out of 11 patents)

13. Bruce Alan Keyt (4 out of 43 patents)

14. Ying-Ping Jiang (4 out of 9 patents)

15. Lauren Opremcak Bakaletz (4 out of 63 patents)

Core Competencies:

Therapeutic Proteins

Anti-DNA Binding Antibodies

Influenza Immunization

Respiratory Syncytial Virus

Biofilm Remediation

Monoclonal Antibodies

Immune Checkpoint Modulation

High Affinity Antibodies

Particulate Labels

Protein Localization Assays

Intermolecular Interaction Detection

High Throughput Microscopy

30 patents: Sort by Forward Citations

1. 12643941 - THERAPEUTIC PROTEIN FORMULATIONS COMPRISING ANTI-DNABII ANTIBODIES AND USES THEREOF (2026-06-02),

2. 12491245 - ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION, AND COMPOSITIONS, COMBINATIONS AND METHODS FOR USE THEREOF (2025-12-09),

3. 12246063 - Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereof (2025-03-11),

4. 12152068 - Binding moieties for biofilm remediation (2024-11-26),

5. 11773143 - Conformational epitopes in respiratory syncytial virus G protein central conserved region (2023-10-03),

6. 11725055 - Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling (2023-08-15),

7. 11248040 - Binding moieties for biofilm remediation (2022-02-15),

8. 11246928 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2022-02-15),

9. 11046764 - Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3 (2021-06-29),

10. 10858431 - Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling (2020-12-08),

11. 10676520 - Antibodies useful in passive influenza immunization (2020-06-09),

12. 10654915 - Antibodies useful in passive influenza immunization (2020-05-19),

13. 10639370 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2020-05-05),

14. 10570193 - Binding moieties for biofilm remediation (2020-02-25),

15. 10233234 - Binding moieties for biofilm remediation (2019-03-19),

Company Overview

Trellis Bioscience, Inc. is a biotechnology company based in Mountain View, California, specializing in the discovery and development of therapeutic antibodies. The organization leverages advanced technologies to identify and characterize immune responses, focusing on innovative solutions for various diseases. Trellis aims to enhance the understanding of the immune system and improve treatment options through its cutting-edge research in antibody engineering and immunology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

30 Patents

#103 in Mountain View, CA

#2,677 in California

#11,257 in US

#21,853 in the World

Mountain View, CA, United States of America

Trellis Bioscience, Inc.

Forward Citations = 169

28 inventors:

Lawrence M Kauvar (30 out of 84 patents)

Angeles Estelles (10 out of 11 patents)

Stefan Ryser (8 out of 8 patents)

4. Orit Foord (7 out of 78 patents)

5. Gizette Sperinde (6 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Trellis Bioscience, Inc.. Retrieved from https://idiyas.com/company/trellis-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…